skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi,
Please explain why RIGL (US) is down today about 22% after it went up yesterday 100% (mid-day).
My exceptions for the stock were to go up & up after RIGL announce it's trial being conducted by Imperial College London to evaluate the efficacy of fostamatinib, its oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of COVID-19 pneumonia
Thanks,
Morris
Read Answer Asked by Morris on July 16, 2020
Q: The above company has come to my attention lately. They appear to have developed a drug NURTEC ODT for pain relief, migraine particularly. I believe the drone just received approval. They are also investors in Kleo Pharmaceuticals working on a Drug for the treatment of COVID-19. I believe Bill and Melinda Gates have just put in 5 million to the same company. I’m just wondering if you were aware of the company and if you are do you have any thoughts about it?

I found this interesting article in Yesterdays Globe and Mail
https://www.theglobeandmail.com/investing/markets/stocks/BHVN-N/pressreleases/88829/

Thanks John
Read Answer Asked by John on July 16, 2020
Q: Hello Wonderful Folks at 5i!
I am just wondering what your thoughts are on the fundamentals and business going forward of this company? Would you consider it a buy for a 2-3 year hold? And would you place it along side (or in the same room) as companies such as Moderno and Innoviva?
Thanks for all you do, your service and the education you provide is unparalleled!
Read Answer Asked by Wes on July 16, 2020
Q: Is there a Canadian company that you would recommend that possibly would benefit from a vaccine to overcome Covid 19, if not what U.S. or international company would you recommend? Thank You.
Read Answer Asked by Brian on July 14, 2020
Q: The recent fall in the share price appears to be the result of the share issue at 0.40, which is well off the market price prior to the issue. So the market got this wrong? Or am I missing something? While phase iii tests appear to be lengthy the commentary was that at this stage risk is much reduced; and other bioT's entering phase iii tests do not seem to suffer as much; and I see no competitor(s) offering comparable benefits. Becoming more concerned than puzzled.
Read Answer Asked by Mike on July 13, 2020
Q: Hi 5i Team - At the risk of asking you to repeat some of the information in your recent answers to questions on Well Health Technologies could you provide some of the fundamentals of this company including cash on hand, debt, insider holdings/recent activity, cash flow, etc. I am interested in taking a small position but given that it is overvalued at this point (with good momentum though) are there any other Canadian companies in the same space that you feel might be a better buy at this point. Thanks.
Read Answer Asked by Rob on July 07, 2020
Q: Hello Peter,
i feel that i have been fooled by Mr Goodman on Knight. I have been patiently waiting as others on a large acquisition and despite the purchase the stock is still languishing . I wonder if it is worth hanging on or throw in the towel. My current thought is take my 5 percent position and reduce it by adding to jamieson wellness and Xebec adsorption. Your thoughts please. Also, TDOC in US is constantly moving higher yet well in Canada (well health ) seems to be in trading range .. Any thoughts please.
Read Answer Asked by umedali on July 07, 2020
Q: I'm curious if come across any companies that would be a good way to invest in wellness clinics. Those offices that often have physiotherapy, massage therapy, chiropractor, acupuncture all in one office.


Between the aging population, working from home with less then ideal ergonomics and people willing to spend more on their health I feel like this area could see continued growth.

Thanks

Read Answer Asked by Dennis on July 07, 2020
Q: I know longer own GUD having sold it over a year ago due to dead money syndrome. However in the G&M today there was an excellent article today on some Canadian biotechs,eg Zyme, etc. that I encourage you to read.

As I've discussed in the past in this column there seemed to be a total vacuum of Biotechs in Canada, but having read this article my eyes are opened.

Are you guys looking into any of these opportunities?

https://www.theglobeandmail.com/business/article-biotech-blind-spot-how-canadas-big-investors-missed-the-boom/

Sheldon
Read Answer Asked by Sheldon on July 07, 2020